Articles
5 Ways Modern MES Solutions for Pharmaceutical Manufacturing
The source highlights the importance of adopting a modern Manufacturing Execution System (MES) in the pharmaceutical industry.
From Discovery to Delivery: The Rise of New Modalities
In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era, where innovation and strategic foresight are paramount. This evolution is not a scientific leap, but also a technological one, fundamentally reshaping the competitive environment.
The New RNA World: Evolving RNA from Messenger to Versatile Therapeutic
RNA has evolved from a molecular messenger into a powerful and versatile therapeutic tool.
From Clinical to Commercial: Streamlining Cold Chain Logistics for Advanced Therapies
Cell and gene therapy (CGT) products require ultra-cold temperatures throughout manufacturing and distribution, posing significant challenges when transitioning from clinical development to commercialization.
Breaking the toxicology bottleneck for IND submissions
With increasingly rapid timelines for achieving IND-ready processes, a bottleneck has emerged in the provision of toxicology data to support INDs for new therapeutics and hence delivery of FIH studies, as Alejandro Fernandez Martell and James Berrie explain in this article originally published in Drug Target Review.
Accelerating the path to clinical filing applications with rapid toxicology material delivery
The application for investigational new drug (IND) and Clinical Trial Application (CTA) is a key step in initiating clinical trials/first-in-human (FIH) trials for a drug candidate.
To build or buy? Examining the pros of building vs. buying a biorepository facility
Biopharma companies face a critical decision: should they invest in building an in-house biorepository or partner with an external provider for their storage and management needs? Each approach has its benefits, from full control and customization to cost savings and scalability.
Partnership-driven value in drug development: Compelling insights from new research
Partnering with a single vendor for comprehensive drug development, manufacturing, research, and clinical supply services can accelerate trial starts and substantially reduce development costs, according to new research by the Tufts Center for the Study of Drug Development.
The Evolution of Antibody Drug Discovery: Unlocking Innovation with Bioinformatics and Al
Since monoclonal antibodies (mAbs) were developed and received their first approval, they became indispensable as research tools and biotherapeutic agents.
Time to Get Level with Your Lab Balance or Analytical Lab Weighing
Analytical weighing plays a crucial role in daily laboratory practices. In basic research, it usually serves as the first step in preparing buffers, media, and reagents.
